Clinical Trial Update: rhTPO in Critical Patients With Thrombocytopenia [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/Phase 3 trial investigates recombinant human thrombopoietin (rhTPO) in critically ill patients with thrombocytopenia, including those with se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Thrombocytopenia

Drugs mentioned

• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Sepsis, Thrombocytopenia | Phase 2, Phase 3 | Status: UNKNOWN